Cheong, I., Deelchand, D. K., Eberly, L. E., Marjańska, M., Manousakis, G., Guliani, G., Walk, D., Öz, G., 2019. Neurochemical correlates of functional decline in amyotrophic lateral sclerosis.. Journal of neurology, neurosurgery, and psychiatry, 90 (3): 294-301.
doi: doi.org/10.1136/jnnp-2018-318795
PubMed ID: 30467209
McClelland, C., Manousakis, G., Lee, M. S., 2016. Progressive External Ophthalmoplegia.. Current neurology and neuroscience reports, 16 (6): 53.
doi: doi.org/10.1007/s11910-016-0652-7
PubMed ID: 27072953
Miller, T. M., Pestronk, A., David, W., Rothstein, J., Simpson, E., Appel, S. H., Andres, P. L., Mahoney, K., Allred, P., Alexander, K., Ostrow, L. W., Schoenfeld, D., Macklin, E. A., Norris, D. A., Manousakis, G., Crisp, M., Smith, R., Bennett, C. F., Bishop, K. M., Cudkowicz, M. E., 2013. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study.. The Lancet. Neurology, 12 (5): 435-42.
doi: doi.org/10.1016/S1474-4422(13)70061-9
PubMed ID: 23541756
Oczko-Walker, M., Manousakis, G., Wang, S., Malter, J. S., Waclawik, A. J., 2010. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.. Journal of clinical neuromuscular disease, 12 (2): 55-61.
doi: doi.org/10.1097/CND.0b013e3181f3dbbf
PubMed ID: 21386771
Sattar, A., Manousakis, G., Jensen, M. B., 2010. Systematic review of reversible cerebral vasoconstriction syndrome.. Expert review of cardiovascular therapy, 8 (10): 1417-21.
doi: doi.org/10.1586/erc.10.124
PubMed ID: 20936928
